Laerdal Medical, founded in 1940 and headquartered in Norway, operates within the manufacturing sector, specifically focusing on medical devices and equipment. The company employs between 1,001 and 5,000 individuals and generates substantial revenue, amounting to approximately 350 million USD. Laerdal Medical is recognized for its contributions to professional training and healthcare, particularly in the realm of emergency medical services. One of its notable initiatives is the T-CPR Quality Improvement Toolkit, designed to enhance the effectiveness of telecommunicators in emergency response settings. This toolkit compiles best practices and provides resources aimed at improving community access to quality improvement tools for cardiac arrest response. The collaboration with organizations such as the Resuscitation Academy and the American Heart Association underscores Laerdal's commitment to enhancing survival rates through effective training and education. The company’s focus on developing resources for telecommunicator cardiopulmonary resuscitation (T-CPR) reflects its dedication to advancing medical training and emergency response capabilities.